| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.33 | 5e-12 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.31 | 2e-11 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-08 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |